These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2275327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H, Bendixen D.
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE, Bedell DM, Jones EW.
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [Abstract] [Full Text] [Related]

  • 5. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
    Ording H, Skovgaard LT.
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
    [Abstract] [Full Text] [Related]

  • 6. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [Abstract] [Full Text] [Related]

  • 7. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F, Roewer N, Köchling A, Scholz J, Löscher W, Steinfath M.
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [Abstract] [Full Text] [Related]

  • 8. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA, Wedel DJ, Gallagher WJ.
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [Abstract] [Full Text] [Related]

  • 9. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
    Hopkins PM, Ellis FR, Halsall PJ, Stewart AD.
    Anesth Analg; 1997 Mar; 84(3):648-56. PubMed ID: 9052318
    [Abstract] [Full Text] [Related]

  • 10. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
    Sudo RT, Cunha LB, Carmo PL, Matos AR, Trachez MM, Cardoso LA, Aguiar MI, Abreu AV, Zapata-Sudo G.
    Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
    [Abstract] [Full Text] [Related]

  • 11. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
    Allen GC, Larach MG, Kunselman AR.
    Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
    [Abstract] [Full Text] [Related]

  • 12. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E, Montigon C, Abriat A, Jouvion A, Duron-Martinaud S, Canini F, Zagnoli F, Bendahan D, Figarella-Branger D, Brégigeon M, Brosset C.
    PLoS One; 2015 Mar; 10(8):e0135496. PubMed ID: 26258863
    [Abstract] [Full Text] [Related]

  • 13. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N, Brum JM, Mitsumoto H, DeBoer GE.
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [Abstract] [Full Text] [Related]

  • 14. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
    Schuster F, Schöll H, Hager M, Müller R, Roewer N, Anetseder M.
    Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
    [Abstract] [Full Text] [Related]

  • 15. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F, Scholz J, Fiege M, Richter A, Steinfath M, Weisshorn R, Schulte am Esch J.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [Abstract] [Full Text] [Related]

  • 16. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
    Ording H, Skovgaard LT.
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590
    [Abstract] [Full Text] [Related]

  • 17. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
    Gilly H, Musat I, Fricker R, Bittner RE, Steinbereithner K, Kress HG.
    Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M, Wappler F, Scholz J, von Richthofen V, Brinken B, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [Abstract] [Full Text] [Related]

  • 19. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
    Melton AT, Antognini JF, Gronert GA.
    Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
    [Abstract] [Full Text] [Related]

  • 20. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF, Girard T, Censier K, Urwyler A.
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.